Your browser doesn't support javascript.
loading
Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine.
Koh, Siang-Boon; Wallez, Yann; Dunlop, Charles R; Bernaldo de Quirós Fernández, Sandra; Bapiro, Tashinga E; Richards, Frances M; Jodrell, Duncan I.
Afiliação
  • Koh SB; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. siangboon.koh@cantab.net.
  • Wallez Y; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Dunlop CR; Harvard Medical School, Boston, Massachusetts.
  • Bernaldo de Quirós Fernández S; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Bapiro TE; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Richards FM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Jodrell DI; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Cancer Res ; 78(11): 3054-3066, 2018 06 01.
Article em En | MEDLINE | ID: mdl-29735549
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Proteínas Nucleares / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Ciclo Celular / Desoxicitidina / Quinase 1 do Ponto de Checagem Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Proteínas Nucleares / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Ciclo Celular / Desoxicitidina / Quinase 1 do Ponto de Checagem Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article